GRAMD1A activators refer to a class of chemical agents that specifically interact with the protein known as GRAMD1A (GRAM Domain Containing 1A). GRAMD1A is a member of the GRAM domain family of proteins, which is characterized by the presence of a GRAM (Glycosyltransferases, Rab-like GTPase activators and Myotubularins) domain, a protein module that is often involved in membrane-associated processes. The protein itself is thought to play a role in cellular lipid homeostasis and may be involved in the intracellular trafficking of lipids and other molecules. Activators of GRAMD1A are compounds that can bind to and increase the activity or the efficiency of the protein, which can result in alterations in the dynamics of lipid handling within cells. These activators may achieve their effects by directly binding to the GRAM domain or other regions of the protein, thereby influencing its structure or its interaction with other cellular components.
Understanding how GRAMD1A activators function requires an in-depth look at their interaction with the protein at a molecular level. These interactions may involve changes in the conformation of GRAMD1A that could affect its binding to other molecules, its localization within the cell, or its overall function in lipid metabolism. Researchers study these activators using a variety of biochemical and biophysical techniques, such as affinity chromatography to isolate the protein-activator complexes, and spectroscopic methods like fluorescence or circular dichroism to assess structural changes upon binding. Additionally, the study of these activators can involve the use of lipidomics to track changes in lipid profiles within the cells and computational modeling to predict how these molecules interact with GRAMD1A. Through these detailed investigations, scientists aim to elucidate the precise mechanisms by which GRAMD1A activators exert their effects on the protein, which in turn sheds light on the fundamental cellular processes governed by GRAMD1A.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $52.00 $89.00 $166.00 $465.00 | 8 | |
As an oxysterol, it could regulate lipid homeostasis and potentially upregulate GRAMD1A as part of feedback mechanisms. | ||||||
GW 3965 hydrochloride | 405911-17-3 | sc-224011 sc-224011A sc-224011B | 5 mg 25 mg 1 g | $137.00 $474.00 $3060.00 | ||
An LXR agonist that may enhance cholesterol efflux and could upregulate genes like GRAMD1A involved in cholesterol homeostasis. | ||||||
T 0901317 | 293754-55-9 | sc-202824 sc-202824A | 10 mg 50 mg | $87.00 $220.00 | 5 | |
Another LXR agonist that can influence cholesterol metabolism and may affect the expression of regulatory proteins such as GRAMD1A. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Affects gene expression, including genes involved in lipid metabolism, which might influence GRAMD1A expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates cAMP levels, which can lead to various changes in gene expression, possibly affecting GRAMD1A. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
As a glucocorticoid, it influences lipid metabolism and might affect GRAMD1A expression indirectly. | ||||||
Chenodeoxycholic acid, free acid | 474-25-9 | sc-278835 sc-278835A | 1 g 5 g | $27.00 $115.00 | ||
Bile acids can regulate lipid metabolism and may potentially modulate the expression of genes like GRAMD1A. | ||||||
β-Cyclodextrin | 7585-39-9 | sc-204430 sc-204430A | 25 g 500 g | $59.00 $527.00 | 3 | |
Can extract cholesterol from cell membranes, potentially altering intracellular cholesterol levels and influencing GRAMD1A expression. | ||||||